Acta Medica

Acta Medica

Association of tumor necrosis factor alpha -238G/A and -308G/A promotor polymorphisms with clearance of Hepatitis B virus infection in Turkish population

Yazarlar: Ahmet Çağkan İnkaya, Emel Türk Arıbaş, İbrahim Erayman, Hasan Acar, Bahar Kandemir, Mehmet Bitirgen

Cilt 50 , Sayı 1 , 2019 , Sayfalar -

Konular:-

Anahtar Kelimeler: HBV,TNFalpha polymorphisms,Chronic viral infection

Özet: Aim: Acute viral hepatitis B may lead to chronic hepatitis in 6% of adult population. We compared the frequency of Tumor necrosis factor alpha promotor polymorphisms in chronic hepatitis B patients and people with natural immunity against hepatitis B. Material and Methodology: Chronic hepatitis B patients and age matched control cases with natural immunity to hepatitis B virus were recruited 1:1 in this study. Tumor necrosis factor alpha -238G/A and -308G/A polymorphisms were studied with PCR-RFLP. χ2 test was performed in statistical analysis. Results: A total of 101 volunteers enrolled in two study groups. Thirty-eight men and 12 women constituted the chronic hepatitis B patient group and 40 men and 11 women recruited in natural immunity group. Frequency of -238G allele was 87.5% and 97% in chronic hepatitis B and natural immunity groups, respectively. Frequency of -308G allel was 93% and 92.1% in chronic hepatitis B and natural immunity groups, respectively. Frequencies of polymorphisms at positions -238 and -308 in the promotor of tumor necrosis factor alpha gene were not different between chronic hepatitis B and natural immunity groups. Conclusion: Tumor necrosis factor alpha promoter polymorphisms at -238 and -308 positions do not effect the outcome hepatitis B infection in Turkish population. Clearance of hepatitis B virus infection is multifactorial. Thus, further studies needed to identify genetic predisposition to chronic hepatitis B infection.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2019, title={Association of tumor necrosis factor alpha -238G/A and -308G/A promotor polymorphisms with clearance of Hepatitis B virus infection in Turkish population}, volume={50}, publisher={Acta Medica}, author={Ahmet Çağkan İnkaya, Emel Türk Arıbaş, İbrahim Erayman, Hasan Acar, Bahar Kandemir, Mehmet Bitirgen}, year={2019} }
APA
KOPYALA
Ahmet Çağkan İnkaya, Emel Türk Arıbaş, İbrahim Erayman, Hasan Acar, Bahar Kandemir, Mehmet Bitirgen. (2019). Association of tumor necrosis factor alpha -238G/A and -308G/A promotor polymorphisms with clearance of Hepatitis B virus infection in Turkish population (Vol. 50). Vol. 50. Acta Medica.
MLA
KOPYALA
Ahmet Çağkan İnkaya, Emel Türk Arıbaş, İbrahim Erayman, Hasan Acar, Bahar Kandemir, Mehmet Bitirgen. Association of Tumor Necrosis Factor Alpha -238G/A and -308G/A Promotor Polymorphisms with Clearance of Hepatitis B Virus Infection in Turkish Population. no., Acta Medica, 2019.